Long-Acting Injectable Cabotegravir/Rilpivirine as a Second-Line ART Regimen for Pregnant and Breastfeeding Women in Kenya: Modeling the Potential Impact on Vertical Transmission
2026Open Forum Infectious DiseasesJournalOpen access
10.1093/ofid/ofag463Full text0 citations